Significant Reduction in Incontinence Episodes with OnabotulinumtoxinA and Clinically Meaningful Improvements in the Practical Aspects of Overactive Bladder Patients’ Daily Lives in Real-world Clinical Practice

Hamid R1, Lorenzo-Gómez M F2, Henrichs T3, Aboushwareb T4, Farrelly E5

Research Type

Clinical

Abstract Category

Overactive Bladder

Abstract 445
Lower Urinary Tract Symptoms
Scientific Podium Short Oral Session 20
Thursday 14th September 2017
14:22 - 14:30
Cavaniglia A
Overactive Bladder Prospective Study Incontinence Urgency Urinary Incontinence Quality of Life (QoL)
1. University College London Hospitals, London, UK, 2. University Hospital of Salamanca, Salamanca, Spain, 3. Ecron Acunova, Frankfurt, Germany, 4. Allergan plc, Irvine, CA, USA, 5. Södersjukhuset, Stockholm South General Hospital, Stockholm, Sweden
Presenter
R

Rizwan Hamid

Links

Abstract